Abstract
PMLRAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.
| Original language | English |
|---|---|
| Pages (from-to) | 554-558 |
| Number of pages | 5 |
| Journal | British journal of cancer |
| Volume | 104 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 15 Feb 2011 |
| Externally published | Yes |
Keywords
- PML-RARa
- PU.1 (SPI1)
- RXR
- epigenome
Fingerprint
Dive into the research topics of 'Genome-wide functions of PML-RARα in acute promyelocytic leukaemia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver